EE05272B1 - Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine - Google Patents

Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine

Info

Publication number
EE05272B1
EE05272B1 EEP200300500A EEP200300500A EE05272B1 EE 05272 B1 EE05272 B1 EE 05272B1 EE P200300500 A EEP200300500 A EE P200300500A EE P200300500 A EEP200300500 A EE P200300500A EE 05272 B1 EE05272 B1 EE 05272B1
Authority
EE
Estonia
Prior art keywords
compounds
derivatives
mercaptoacetamide
preparation
disclosed
Prior art date
Application number
EEP200300500A
Other languages
English (en)
Estonian (et)
Inventor
A. Flynn Gary
Mehdi Shujaath
Roger Koehl Jack
Ann Anderson Barbara
Gerken Manfred
Jablonka Bernd
Kleemann Heinz-Werner
Linz Wolfgang
Seiz Werner
Seuring Bernhard
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119305.1A external-priority patent/GB0119305D0/en
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200300500A publication Critical patent/EE200300500A/xx
Publication of EE05272B1 publication Critical patent/EE05272B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
EEP200300500A 2001-04-12 2002-04-03 Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine EE05272B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28330501P 2001-04-12 2001-04-12
GBGB0119305.1A GB0119305D0 (en) 2001-04-12 2001-08-08 Mercaptoacetylamide derivatives,a process for their preparation and their use
PCT/EP2002/003668 WO2002083671A1 (fr) 2001-04-12 2002-04-03 Derives de mercaptoacetylamide, procede de preparation et utilisation de ces composes

Publications (2)

Publication Number Publication Date
EE200300500A EE200300500A (et) 2003-12-15
EE05272B1 true EE05272B1 (et) 2010-02-15

Family

ID=26246410

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300500A EE05272B1 (et) 2001-04-12 2002-04-03 Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine

Country Status (27)

Country Link
EP (1) EP1381605B1 (fr)
JP (1) JP4392167B2 (fr)
CN (1) CN1245404C (fr)
AT (1) ATE286898T1 (fr)
AU (1) AU2002304804B2 (fr)
BG (1) BG66387B1 (fr)
BR (1) BR0208889A (fr)
CA (1) CA2443488C (fr)
CZ (1) CZ299708B6 (fr)
DE (1) DE60202602T2 (fr)
EE (1) EE05272B1 (fr)
ES (1) ES2232752T3 (fr)
HK (1) HK1061690A1 (fr)
HR (1) HRP20030823B1 (fr)
HU (1) HU229612B1 (fr)
IL (1) IL158289A0 (fr)
MA (1) MA26098A1 (fr)
MX (1) MXPA03008613A (fr)
NO (1) NO325655B1 (fr)
NZ (1) NZ528825A (fr)
OA (1) OA12502A (fr)
PL (1) PL209338B1 (fr)
PT (1) PT1381605E (fr)
RU (1) RU2286346C2 (fr)
SI (1) SI1381605T1 (fr)
SK (1) SK287616B6 (fr)
WO (1) WO2002083671A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229180A1 (de) * 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2053340C (fr) * 1990-10-18 2002-04-02 Timothy P. Burkholder Derives de mercaptoacetylamide utiles comme inhibiteurs de l'encephalinase et de l'ace
EP0534363B1 (fr) * 1991-09-27 1997-07-09 Merrell Pharmaceuticals Inc. Dérivés d'indane-2-mercaptoacétylamide ayant une activité inhibitante d'enképhalinase et d'ACE
CN1110865A (zh) * 1993-06-11 1995-10-25 卫材株式会社 氨基酸衍生物

Also Published As

Publication number Publication date
NO20034412D0 (no) 2003-10-02
NO20034412L (no) 2003-10-02
HU229612B1 (en) 2014-03-28
MXPA03008613A (es) 2003-12-08
HUP0303482A3 (en) 2012-12-28
CZ299708B6 (cs) 2008-10-29
EP1381605A1 (fr) 2004-01-21
SK12552003A3 (sk) 2004-03-02
CA2443488C (fr) 2011-05-31
DE60202602T2 (de) 2006-03-23
MA26098A1 (fr) 2004-04-01
DE60202602D1 (de) 2005-02-17
BR0208889A (pt) 2004-06-29
NO325655B1 (no) 2008-06-30
IL158289A0 (en) 2004-05-12
EP1381605B1 (fr) 2005-01-12
PL209338B1 (pl) 2011-08-31
RU2003132875A (ru) 2005-03-20
CA2443488A1 (fr) 2002-10-24
CN1501926A (zh) 2004-06-02
BG108203A (bg) 2004-12-30
EE200300500A (et) 2003-12-15
HUP0303482A2 (hu) 2004-01-28
SI1381605T1 (en) 2005-06-30
JP2004525966A (ja) 2004-08-26
BG66387B1 (bg) 2013-11-29
ATE286898T1 (de) 2005-01-15
AU2002304804B2 (en) 2007-05-10
CN1245404C (zh) 2006-03-15
PT1381605E (pt) 2005-03-31
HK1061690A1 (en) 2004-09-30
SK287616B6 (sk) 2011-04-05
JP4392167B2 (ja) 2009-12-24
PL363034A1 (en) 2004-11-15
HRP20030823A2 (en) 2005-08-31
NZ528825A (en) 2005-04-29
WO2002083671A1 (fr) 2002-10-24
ES2232752T3 (es) 2005-06-01
HRP20030823B1 (en) 2011-10-31
RU2286346C2 (ru) 2006-10-27
CZ20032722A3 (cs) 2004-01-14
OA12502A (fr) 2006-05-29

Similar Documents

Publication Publication Date Title
TNSN03083A1 (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
TR200100238T2 (tr) Yeni sübstitüe edilmiş pirazol türevleri
WO2002100845A8 (fr) Inhibiteurs de protease du hiv et compositions contenant ceux-ci, leurs applications pharmaceutiques, et matieres utiles a la synthese de ces inhibiteurs
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
WO2003082857A3 (fr) Polymorphes de lansoprazole et procedes de preparation de ces derniers
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
WO2004012663A3 (fr) Derives d'yhydantoine utilises comme inhibiteurs de metalloproteases maticielles et/ou d'enzyme de conversion de tnf-alpha
WO2004050663A3 (fr) Procede ameliore de preparation de cefuroxime sodique
SG165159A1 (en) Process for preparing 6-alkylidene penem derivatives
EE05272B1 (et) Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
EP1436279B8 (fr) Composes chimiques
WO2003028645A3 (fr) Nouvelles compositions de carvedilol
WO2002085877A3 (fr) Procedes et intermediaires de preparation de benzyl epoxydes
MXPA05003881A (es) Preparacion de compuestos triazospiro.
WO2002010124A3 (fr) Sels d'un inhibiteur de la protease du vih
DE60120398D1 (de) Imidazopyridin-8-one
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
WO2002083641A3 (fr) Amino-aza-cyclohexanes
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.
AU2001244537A1 (en) Use of natural compounds having antiangiogenic activity

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20160403